STOCKS TELEGRAPH

Tag: ARPO

  • Aerpio Pharmaceuticals, Inc. (ARPO) Stock Surges After Being Massively Upgraded by Analysts

    Aerpio Pharmaceuticals, Inc. (ARPO) Stock Surges After Being Massively Upgraded by Analysts

    Aerpio Pharmaceuticals, Inc. (ARPO) stock prices skyrocketed by 69.0059% some time after market trading commenced on July 8th, 2021, bringing the price per share up to USD$2.89 earlier in the trading day.

    Upgrading of ARPO Stock

    Analyst Robert Burns of H.C Wainwright upgraded ARPO from a Neutral rating to a Buy, with the company’s stock being given a USD$22 price target. Burns cited the transformative nature of the merger as being the driving force behind the upgrading of the company. Furthermore, the merger is expected to facilitate the transition to a self-sustaining, commercial-stage enterprise, with a distinguished flagship product that boasts applicability across a myriad of oncology indications.

    Merger with Aadi Bioscience

    May 16th, 2021 saw the company announce its strategic merger with Aadi Bioscience, Inc. and Aspen Merger Subsidiary, Inc. The agreement will see Aadi surviving the merger as a wholly-owned subsidiary of ARPO, with both companies’ Board of Directors having given their approval. Following the merger, ARPO will continue as Aadi Bioscience and will focus on the development of FYARRO.

    PIPE Financing

    In connection to the merger, ARPO entered into subscription agreements to raise up to USD$155 million in Private Investment in Public Equity (PIPE) financing. The PIPE will see shares of the company’s common stock and pre-funded warrants being used to purchase Aerpio’s common stock. This move is expected to be executed at the same time as the closing of the merger, as per customary closing conditions and the closing of the merger itself.

    Solid Liquidity Position

    March 31st, 2021 saw the company report USD$39 million in cash and cash equivalents, down from the USD$42.6 million reported as of December 31st, 2020. ARPO reported a total of almost 47.4 million common shares outstanding as of March 31st, 2021, with weighted average common shares, both basic and diluted, outstanding totaling 47.3 million as of the end of the quarter.

    R&D Expenses

    The first quarter of fiscal 2021, ended March 31st, 2021, saw ARPO report USD$2.2 million in research and development costs, up 21.8% from the USD$1.8 million reported for the three-month period ended March 31st, 2020. This year-over-year difference was largely driven by increased expenses associated with the company’s clinical programs.

    Net Loss Reports

    Net loss attributable to common stockholders was USD$4.4 million for the quarter ended March 31st 2021, representing a net loss of USD$0.09 per common share. This is comparable to the USD$3.9 million in net loss reported for Q1 2020, which came out to a net loss of USD$0.10 per common share.

    Future Outlook for ARPO

    Armed with the massive scope in light of its recent merger, ARPO is poised to capitalize on the expanded opportunities afforded to it. The company is keen to leverage its combined resources to usher in sustained and organic growth over the long term. With a target price of USD$22.00, investors are snowballing the growth as it climbs higher and higher towards that goal.

  • 31 stocks trending in pre-market

    31 stocks trending in pre-market

    NIO Limited (NIO) stock soared 2.95% to $42.19 in the pre-market trading following the pricing of offering of 68,000,000 American depositary shares. The most recent rating by Goldman, on December 01, 2020, is a Neutral. NIO Inc.

    Veru Inc. (NASDAQ: VERU) shares are trading up 7.17% at $10.39 at the time of writing after declaring positive Phase 2 clinical trial results for enobosarm, for the treatment of endocrine and chemotherapy resistant ER+/HER2- metastatic breast cancer, which was selected as a Spotlight Presentation at the 2020 San Antonio Breast Cancer Symposium. Company’s 52-week ranged between $2.10 to $7.86. Analysts have a consensus price target of $6.

    Occidental Petroleum Corporation (OXY) stock soared 2.45% to $19.64 in the pre-market trading. The most recent rating by MKM Partners, on December 07, 2020, is a Neutral.

    BioCardia Inc. (BCDA), a Biotechnology company, rose about 9.38% at $4.9 in pre-market trading Tuesday after reporting entry into definitive agreements with investors for the purchase and sale of 1,789,474 shares of its common stock at a purchase price of $4.75 per share in a registered direct offering priced at-the-market under Nasdaq rules.

    Genius Brands International Inc. (GNUS) gained over 15.85% at $2.12 in pre-market trading Tuesday December 15, 2020. The company recently revealed that it has secured a commitment to receive $100 million in cash on January 15, 2021 from New York-based Mudrick Capital Management as a result of a new first lien debt financing.

    Nikola Corporation (NKLA) is up more than 2.38% at $16.8 in pre-market hours Tuesday December 15, 2020. The stock had dropped over -6.87% to $16.41 in the last trading session.

    Virgin Galactic Holdings Inc. (SPCE) is up more than 2.83% at $27.22 in pre-market hours Tuesday December 15, 2020 following an update on test flight program. The stock had dropped over -17.38% to $26.47 in the last trading session.

    Before the trading started on December 15, 2020, Huntington Bancshares Incorporated (HBAN) is up 2.32% to reach $12.8 after reporting merger with TCF Financial Corporation to create top 10 U.S. regional bank. It has been trading in a 52-week range of $6.82 to $15.63.

    Plug Power Inc. (PLUG) stock soared 2.65% to $26.38 in the pre-market trading. The most recent rating by B. Riley Securities, on November 10, 2020, is a Buy.

    XPeng Inc. (NYSE: XPEV) shares are trading up 3.86% at $48.99 at the time of writing after its P7 super-long range sports sedan received car of the Year 2021 award in Xuanyuan Awards. Company’s 52-week ranged between $17.11 to $74.49. Analysts have a consensus price target of $58.

    AnPac Bio-Medical Science Co. Ltd. (ANPC), a Biotechnology company, dropped about -5.26% at $5.4 in pre-market trading Tuesday following the proclamation from the firm that it has made significant progress in detecting pre-cancer diseases.

    Yamana Gold Inc. (AUY) stock moved up 2.66 percent to $5.4 in the pre-market trading.

    Zynga Inc. (ZNGA) gained over 3.9% at $9.05 in pre-market trading Tuesday December 15, 2020 following the declaration of pricing of offering of $762 million of convertible senior notes.

    IZEA Worldwide Inc. (IZEA) is down more than -5.68% at $0.9243 in pre-market hours Tuesday December 15, 2020 after announcing that it has seen a surge of new customers in Q4 2020. The stock had jumped over 15.00% to $0.98 in the last trading session.

    Cameco Corporation (CCJ) grew over 3.16% at $13.7 in pre-market trading today.

    Before the trading started on December 15, 2020, HEXO Corp. (HEXO) is down -2.8% to reach $0.9817 after releasing its first quarter fiscal 2021 financial results. It has been trading in a 52-week range of $0.35 to $2.30.

    Nano Dimension Ltd. (NNDM) stock soared 1.8% to $6.77 in the pre-market trading. The most recent rating by Maxim Group, on October 21, 2016, is a Buy.

    Teligent Inc. (TLGT) tumbled over -3.53% at $0.78 in pre-market trading today.

    Synlogic Inc. (NASDAQ: SYBX) shares are trading down -5.51% at $2.4 at the time of writing following advancement of SYNB1891 to combination arm dosing with PD-L1 checkpoint inhibitor in the on-going phase 1 study for the treatment of solid tumors and lymphoma. Company’s 52-week ranged between $1.35 to $3.99.

    BioNTech SE (BNTX) stock soared 5.48% to $114.2 in the pre-market trading. The most recent rating by BofA Securities, on December 01, 2020, is a Neutral. Pfizer Inc. (PFE) and BioNTech SE (BNTX) recently declared additional data on neutralizing antibody and T cell responses from the Phase 1/2 trial with BNT162b2 conducted in Germany

    Torchlight Energy Resources Inc. (TRCH) tumbled over -12.14% at $0.543 in pre-market trading today.

    Seelos Therapeutics Inc. (SEEL) stock moved up 5.47 percent to $1.35 in the pre-market trading after revealing the sale of a $12.0 million senior secured convertible note and shares of Seelos common stock to investors.

    Bed Bath & Beyond Inc. (BBBY) gained over 4.35% at $19.69 in pre-market trading Tuesday December 15, 2020 following the declaration of definitive agreement to sell its remaining non-core banner Cost Plus World Market (CPWM) to Kingswood Capital Management, a Los Angeles-based private equity firm.

    Before the trading started on December 15, 2020, Aerpio Pharmaceuticals Inc. (ARPO) is down -3.33% to reach $1.16. It has been trading in a 52-week range of $0.42 to $2.31.

    Before the trading started on December 15, 2020, Energy Fuels Inc. (UUUU) is up 2.94% to reach $3.15 after reporting that it has entered into a three-year supply agreement with The Chemours Company (CC) to acquire a minimum of 2,500 tons per year of natural monazite sands. It has been trading in a 52-week range of $0.78 to $3.10.

    Uranium Energy Corp. (UEC) grew over 5.62% at $1.69 in pre-market trading today after filing fiscal 2021 Q1 quarterly report.

    MicroVision Inc. (MVIS), a Scientific & Technical Instruments company, rose about 5.43% at $3.3 in pre-market trading Tuesday.

    NovaBay Pharmaceuticals Inc. (NBY) is down more than -2.28% at $0.68 in pre-market hours Tuesday December 15, 2020 after reporting that its proprietary hypochlorous acid solution has received U.S. Environmental Protection Agency (EPA) approval for a kill claim against SARS-CoV-2, the virus that causes COVID-19. The stock had jumped over 0.86% to $0.70 in the last trading session.

    vTv Therapeutics Inc. (VTVT), a Biotechnology company, dropped about -10.44% at $2.66 in pre-market trading Tuesday after declaring a licensing agreement with Anteris Bio for worldwide rights to vTv’s novel clinical-stage Nrf2 activator compound, HPP971.

    Socket Mobile Inc. (NASDAQ: SCKT) shares are trading down -15.38% at $2.42 at the time of writing. Company’s 52-week ranged between $0.76 to $4.50.

    ArcelorMittal (MT) grew over 4.3% at $22.08 in pre-market trading today after announcing investment agreement with Invitalia, an Italian state-owned company.

  • What changed for these 30 stocks in Pre Market Session

    What changed for these 30 stocks in Pre Market Session

    Usio Inc. (USIO) stock soared 41.54% to $2.59 in the pre-market trading after declaring that it has entered into a non-binding Letter of Intent (LOI) to acquire the assets of Information Management Solutions, LLC (IMS).
    NeuroMetrix Inc. (NURO), a Medical Instruments & Supplies company, dropped about -8.03% at $2.75 in pre-market trading Wednesday.
    Cinedigm Corp. (CIDM) stock moved up 43.36 percent to $1.23 in the pre-market trading following a strategic alliance with Spherex to drive Cinedigm’s global growth.
    Recon Technology Ltd. (RCON) stock moved up 112.5 percent to $3.06 in the pre-market trading.
    Curis Inc. (NASDAQ: CRIS) shares are trading up 2.29% at $6.7 at the time of writing after revealing proposed public offering of common Stock. Company’s 52-week ranged between $0.62 to $3.59. Analysts have a consensus price target of $5.
    Gran Tierra Energy Inc. (GTE) lost over -7.04% at $0.355 in pre-market trading Wednesday December 09, 2020. The firm recently declared a financial update and the Company’s 2021 capital budget and production guidance.
    Aurora Cannabis Inc. (ACB) is down more than -0.94% at $10.5 in pre-market hours Wednesday December 09, 2020. The stock had jumped over 1.24% to $10.60 in the last trading session.
    Carnival Corporation & Plc (CCL) is up more than 2.76% at $24.22 in pre-market hours Wednesday December 09, 2020 following declaration of Cunard, a part of Carnival Corporation & plc (CCL), that it has extended its pause in operations due to the ongoing travel constraints in place across the world. The stock had jumped over 1.59% to $23.57 in the last trading session.
    Before the trading started on December 09, 2020, Occidental Petroleum Corporation (OXY) is up 2.56% to reach $19.62 after reporting upsize of previously announced cash tender offers and consent solicitations for certain of its senior notes. It has been trading in a 52-week range of $8.52 to $47.58.
    Virgin Galactic Holdings Inc. (SPCE) stock soared 2.55% to $34.24 in the pre-market trading. The most recent rating by Goldman, on October 23, 2020, is a Neutral.
    Eastman Kodak Company (NYSE: KODK) shares are trading down -4.04% at $10.7 at the time of writing after getting clean chit from U.S government regarding a government loan. Company’s 52-week ranged between $1.50 to $60.00.
    Moderna Inc. (MRNA) grew over 3.38% at $175.6 in pre-market trading today after declaring that the Swiss Federal Government has increased its confirmed order commitment from 4.5 million to 7.5 million doses of Moderna’s vaccine candidate against COVID-19, mRNA-1273.
    Riot Blockchain Inc. (RIOT), a Software – Application company, dropped about -5.78% at $9.3 in pre-market trading Wednesday.
    Norwegian Cruise Line Holdings Ltd. (NCLH), a Travel Services company, rose about 1.95% at $28.7 in pre-market trading Wednesday after announcing partnership with AtmosAir Solutions.
    XPeng Inc. (XPEV) stock moved down -3.72 percent to $46.88 in the pre-market trading following the pricing of follow-on public offering of American depositary shares.
    Cinemark Holdings Inc. (CNK) stock soared 2.26% to $15.36 in the pre-market trading. The most recent rating by Loop Capital, on November 19, 2020, is a Hold.
    Before the trading started on December 09, 2020, Tonix Pharmaceuticals Holding Corp. (TNXP) is up 0.15% to reach $0.65 after declaring results of positive phase 3 RELIEF study for TNX-102 SL 5.6 mg in Fibromyalgia. It has been trading in a 52-week range of $0.39 to $2.46.
    CBAK Energy Technology Inc. (NASDAQ: CBAT) shares are trading up 3.3% at $5.95 at the time of writing following the publication of securities purchase agreement with certain institutional investors for a registered direct placement of approximately $49.2 million of common stock at a price of $5.18 per share. Company’s 52-week ranged between $0.36 to $11.40.
    Jaguar Health Inc. (NASDAQ: JAGX) shares are trading down -4.84% at $0.3798 at the time of writing. Company’s 52-week ranged between $0.19 to $1.08. Analysts have a consensus price target of $2.
    United Airlines Holdings Inc. (UAL) grew over 1.88% at $49.96 in pre-market trading today after launching virtual, on demand customer service at the airport.
    GameStop Corp. (GME) is down more than -17.59% at $13.96 in pre-market hours Wednesday December 09, 2020 after releasing results for the third quarter ended October 31, 2020. The stock had jumped over 3.61% to $16.94 in the last trading session.
    Before the trading started on December 09, 2020, ADMA Biologics Inc. (ADMA) is up 4.31% to reach $2.18. It has been trading in a 52-week range of $1.45 to $4.65.
    Before the trading started on December 09, 2020, HEXO Corp. (HEXO) is down -2.91% to reach $1.0. The firm recently reported downward revision to its proposed share consolidation ratio. It has been trading in a 52-week range of $0.35 to $2.30.
    United Microelectronics Corporation (UMC) is up more than 1.37% at $8.88 in pre-market hours Wednesday December 09, 2020 afterreporting unaudited net sales for the month of November 2020. The stock had dropped over -3.10% to $8.76 in the last trading session.
    Apache Corporation (NASDAQ: APA) shares are trading up 1.08% at $14.92 at the time of writing following the board of directors of Apache Corporation (APA) has declared a regular cash dividend on the company’s common shares. Company’s 52-week ranged between $3.80 to $33.77. Analysts have a consensus price target of $16.
    Phunware Inc. (PHUN) stock moved down -3.28 percent to $0.81 in the pre-market trading after revealing its receipt of the Privacy Shield certification.
    Sorrento Therapeutics Inc. (SRNE) stock soared 9.62% to $8.66 in the pre-market trading after declaring that it has received CLIA Licensure from the State of California that permits testing of clinical samples. The most recent rating by H.C. Wainwright, on July 31, 2020, is a Buy.
    Sesen Bio Inc. (SESN) gained over 5.42% at $1.75 in pre-market trading Wednesday December 09, 2020 following the announcement of commercial manufacturing and global supply partnership with Qilu Pharmaceutical.
    Before the trading started on December 09, 2020, Futu Holdings Limited (FUTU) is up 2.27% to reach $44.61 after reporting that a leading global investment firm has agreed to purchase approximately 50,000,000 Class A ordinary shares of the Company in the form of prepaid warrants for an aggregate purchase price of approximately US$260,000,000. It has been trading in a 52-week range of $8.16 to $51.10.
    Westwater Resources Inc. (WWR) stock soared 3.87% to $5.63 in the pre-market trading. The company recently provided an update on progress at its pilot plant operations at Dorfner Anzaplan’s facilities near Amberg, Germany, as well as at facilities in Frankfort, Germany, Chicago, Illinois, and Buffalo, New York.

  • 15 Trending Stocks in Biotechnology Industry

    15 Trending Stocks in Biotechnology Industry

    This year, biotech companies on the stock exchange have skyrocketed. This is no surprise since biotech firms are the leaders in the battle against the coronavirus pandemic. Even with Pfizer’s first vaccine in the UK, investors and pharmaceutical companies are well aware that the race is far ahead.
    Other diseases should not be ignored apart from coronavirus vaccines. The biotech sector is also creating headlines and innovating in areas linked to dementia, cancer, hereditary disorders, etc. Given the above, buyers are probably faced with the difficulty of choosing the best ones to purchase.

    Curis Inc. (NASDAQ:CRIS) shares were trading up 354.86% at $6.55 at the time of writing on Tuesday following announcement of proposed public offering of common stock.

    Curis Inc. (NASDAQ:CRIS) share price went from a low point around $0.62 to briefly over $3.59 in past 52 weeks, though shares have since pulled back to $6.55. CRIS market cap has remained high, hitting $409.70M at the time of writing, giving it price-to-sales ratio of more than 30.

    If we look at the recent analyst rating CRIS, Laidlaw initiated coverage on CRISshares with a Buy rating.

    Lexicon Pharmaceuticals Inc. (LXRX) last closed at $3.08, in a 52-week range of $1.03 to $5.33. Analysts have a consensus price target of $2.37. On November 17, 2020, the firmreported that both the SOLOIST and SCORED Phase 3 studies achieved their primary endpoints by demonstrating statistically significant reductions in total cardiovascular deaths, hospitalizations for heart failure and urgent heart failure visits in patients treated with sotagliflozin as compared with placebo.

    IGM Biosciences Inc. (IGMS) stock soar by 57.75% to $115.03 after declaringpricing of upsized $200 million public offering. The most recent rating by Robert W. Baird, on July 17, 2020, is at an Outperform.

    Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Shares headed rising, higher as much as 29.44%. The company will hold a conference call on Wednesday, December 9, 2020 at 10:00 a.m. ET to discuss clinical data from ongoing studies evaluating eganelisib in triple negative breast cancer (TNBC) The most recent rating by Oppenheimer, on June 27, 2019, is at an Outperform.

    Oncternal Therapeutics Inc. (NASDAQ:ONCT) rose 27.64% after gaining more than $1.1 on Tuesday after reporting updated interim clinical data from the ongoing Phase 1/2 CIRLL (Cirmtuzumab and Ibrutinib targeting ROR1 for Leukemia and Lymphoma) clinical trial.

    Proteostasis Therapeutics Inc. (PTI) last closed at $1.23, in a 52-week range of $0.87 to $4.72. The firm reported on November 16, 2020. a net loss of approximately $8.2 million for the three months ended September 30, 2020, as compared to a net loss of $12.8 million for the same period in the prior year.

    InflaRx N.V. (IFRX) stock soar by 18.27% to $4.79. The most recent rating by SVB Leerink, on November 06, 2020, is at an Outperform.

    Syros Pharmaceuticals Inc. (NASDAQ:SYRS) Shares headed rising, higher as much as 17.47% after closing $90.5 million strategic financing. The most recent rating by H.C. Wainwright, on November 04, 2020, is at a Buy.

    Aerpio Pharmaceuticals Inc. (NASDAQ:ARPO) rose 16.28% after gaining more than $0.28 on Tuesday.

    Ampio Pharmaceuticals Inc. (AMPE) last closed at $1.35, in a 52-week range of $0.31 to $1.39. The firm recently revealed that it will conduct its annual meeting in a virtual format only on December 12, 2020 at 9:00 am MST.

    Regulus Therapeutics Inc. (RGLS)stock soar by 15.19% to $0.93 following the closing of $19.4 million private placement of equity. The most recent rating by B. Riley FBR Inc., on March 28, 2018, is at a Neutral.

    Cancer Genetics Inc. (NASDAQ:CGIX) Shares headed rising, higher as much as 14.79%. The most recent rating by Maxim Group, on December 07, 2017, is at a Buy.

    Marinus Pharmaceuticals Inc. (NASDAQ:MRNS) fall -11.85% after losing more than -$1.85 on Tuesday. The healthcare firm lately declared pricing of $70 million public offering of common stock, which is expected to close on or about December 10, 2020.

    iBio Inc. (IBIO) last closed at $1.31, in a 52-week range of $0.19 to $7.45 after declaring pricing of $35 million public offering of common stock. Analysts have a consensus price target of $2.00.

    Vaccinex Inc. (VCNX) stock soar by 14.08% to $2.35. The most recent rating by BTIG Research, on September 23, 2020, is at a Neutral.

  • Top 3 Pre-Market Performers as Strong Earnings in Europe Lift Optimism in the Equity Markets

    Top 3 Pre-Market Performers as Strong Earnings in Europe Lift Optimism in the Equity Markets

    There is high optimism in the equity markets this morning driven by progress on economic bailout talks, and strong earnings by corporations across the Atlantic. Yesterday Democratic Senate Minority Leader Chuck Schumer stated that while they were still far off from a deal, they were still going.

    Across the Atlantic in Europe, several corporations have reported positive earnings with several others raising their outlook for the year. This points to the resilience of the global markets even as the COVID-19 pandemic continues to bite, and is a key factor to stock markets optimism.  Markets are also being supported by the upcoming trade discussions on August 15th between the U.S and China.  In this environment of improved market sentiment, here are some of the biggest gainers ahead of markets opening:

    Aerpio Pharmaceuticals Inc [NASDAQ:ARPO]

    Aerpio Pharmaceuticals Inc is a top performer this morning and is up by over 50%. The stock’s rally follows the company’s announcement of the 2nd clinical trial that will help test Razuprotafib in treating ARDS in people with mild to severe COVID-19.  The clinical trial is part of the MTEC-20-09-COVID-19 Treatment Military Infectious Disease Research Program (MIDRP).  The company announced that as a facilitation for the program, it will receive $5.1 million from MTEC. On its part, Aerpio stated that it would support the program with $2.8 million.

    MicroVision Inc [NASDAQ:MVIS]

    MicroVision is another top performer this morning and is up by over 16% in pre-market trading. The stock’s rally follows news that the company could be up for a buyout. According to the Motley Fool, CEO Sumit Sharma stated that they were considering offers from major companies in the auto and augmented reality industry.  While the CEO did not offer details on the amount being offered, analysts project that it could be close to the company’s present market cap. This seems to have excited the market if the stock’s pre-market price action is anything to go by.

    Acorda Therapeutics Inc [NASDAQ:ACOR]

    Acorda is another top performer pre-market and is currently up by 26%. The rally follows the release of Q2 results that beat analysts’ expectations.  The analyst consensus was an EPS loss of 0.46, while the company reported an EPS loss of $0.35. The company’s EPS loss also represented an improvement compared to the last financial year when its loss per share was $0.55.  The company attributed this improvement to a 7% increase in net sales, despite the challenges posed by the COVID-19 pandemic.